Senti Biosciences Inc.

NASDAQ: SNTI · Real-Time Price · USD
1.55
0.02 (1.31%)
At close: Aug 15, 2025, 3:59 PM
1.50
-3.19%
After-hours: Aug 15, 2025, 07:51 PM EDT

Senti Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 5.86M n/a n/a n/a 333K 255K 937K 1.04M 59K 1.77M 1.11M 854K 543K 926K 778K 72K
Cost of Revenue
1.48M n/a 2.93M n/a 1.47M 1.46M 1.47M 25.69M 1.21M 11.32M 944K n/a 1.73M 7.6M 6.41M 253.46K 5.24M 4.9M
Gross Profit
-1.48M n/a 2.93M n/a -1.47M -1.46M -1.14M -25.44M -274K -10.28M -885K 1.77M -625K -6.75M -5.87M 672.54K -4.46M -4.83M
Operating Income
-16.8M -16.4M -16.17M -15.21M -13.36M -16.3M -18.43M -43.88M -19.64M -19.83M -20.02M -17.09M -21.77M -11.76M -10.88M -11.42M -9M -1.18K
Interest Income
270K 394K -717K 150K 236K 331K 426K 583K 794K 1.06M 1.13M 542K 27K 4K 4K 5K 2K n/a
Pretax Income
-14.73M -14.11M -610K -28.87M -11.2M -12.11M -18.69M -36.62M -18.7M -18.72M -18.21M -16.64M -11.55M -11.81M -10.9M -11.41M -12.01M -1.18K
Net Income
-14.73M -14.11M -610K -28.87M -11.2M -12.11M -18.72M -14.92M -18.7M -18.72M -18.21M -16.64M -11.55M -11.81M -10.9M -11.41M -12.01M -1.18K
Selling & General & Admin
5.52M 7.12M 10.31M 6.25M 3.49M 6.32M 7.83M 9.43M 9.62M 9.8M 10.91M 10.79M 13.88M 5.26M 5.27M 7.12M 4.55M 1.18K
Research & Development
9.8M 9.28M 8.03M 8.65M 9.15M 8.52M 9.12M 9.09M 10.95M 11.32M 9.16M 8.06M 9.25M 7.6M 6.41M 5.41M 5.24M 4.9M
Other Expenses
n/a n/a n/a 313K n/a n/a n/a 885K 938K -250K 1.81M n/a -250K -250K -10K 21K -3.01M n/a
Operating Expenses
15.32M 16.4M 18.34M 15.21M 13.36M 14.84M 16.95M 18.44M 20.57M 20.87M 20.07M 18.85M 22.88M 12.61M 11.43M 12.35M 9.77M 1.18K
Interest Expense
n/a n/a n/a n/a n/a n/a 1.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a 2.41M n/a -1.21M -1.2M 834K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.31M
Cost & Expenses
16.8M 16.4M 21.27M 15.21M 13.36M 16.3M 18.43M 18.44M 20.57M 20.87M 20.07M 18.85M 22.88M 12.61M 11.43M 12.35M 9.77M 1.18K
Income Tax Expense
n/a n/a n/a n/a n/a n/a 28K n/a -1.21M -1.11M n/a -1.03M n/a -23.16K 9K 4K n/a n/a
Shares Outstanding (Basic)
26.08M 4.6M 4.6M 4.58M 4.57M 4.57M 4.5M 4.45M 4.43M 4.41M 4.38M 4.34M 4.35M 4.37M 4.37M 4.37M 4.37M 2.95M
Shares Outstanding (Diluted)
26.08M 4.6M 4.6M 4.58M 4.57M 4.57M 4.5M 4.45M 4.43M 4.41M 4.38M 4.34M 4.35M 4.37M 4.37M 4.37M 4.37M 2.95M
EPS (Basic)
-0.56 -3.07 -0.13 -6.31 -2.45 -2.65 -4.16 -3.36 -4.22 -4.25 -4.16 -3.83 -2.65 -2.7 -2.5 -2.61 -2.75 -0.00
EPS (Diluted)
-0.56 -3.07 -0.13 -6.31 -2.45 -2.65 -4.16 -3.36 -4.22 -4.25 -4.16 -3.83 -2.65 -2.7 -2.5 -2.61 -2.75 -0.00
EBITDA
-13.26M -14.93M -5M -13.44M -11.89M -14.84M -17.21M -15.94M -17.49M -17.79M -19.57M -15.61M -21.77M -11.52M -10.66M -11.23M -8.81M -1.18K
EBIT
-14.73M -14.11M 44.56M -14.9M -13.36M -16.3M -18.43M -18.18M -18.7M -18.72M -20.02M -14.75M -21.77M -11.76M -10.88M -11.42M -9M -1.18K
Depreciation & Amortization
1.48M 1.47M -4.39M 1.46M 1.47M 1.46M 1.47M 1.81M 1.21M 929K 944K 1.03M 1.73M 1.01M 1.03M 872K 182K 165K